Annual Revenue
$20.97 M
-$20.90 M-49.92%
31 December 2023
Summary:
Cara Therapeutics annual revenue is currently $20.97 million, with the most recent change of -$20.90 million (-49.92%) on 31 December 2023. During the last 3 years, it has fallen by -$114.11 million (-84.48%). CARA annual revenue is now -84.48% below its all-time high of $135.08 million, reached on 31 December 2020.CARA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$2.56 M
+$1.56 M+157.92%
30 September 2024
Summary:
Cara Therapeutics quarterly revenue is currently $2.56 million, with the most recent change of +$1.56 million (+157.92%) on 30 September 2024. Over the past year, it has dropped by -$2.31 million (-47.47%). CARA quarterly revenue is now -97.72% below its all-time high of $112.09 million, reached on 31 December 2020.CARA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$8.69 M
-$2.31 M-21.01%
30 September 2024
Summary:
Cara Therapeutics TTM revenue is currently $8.69 million, with the most recent change of -$2.31 million (-21.01%) on 30 September 2024. Over the past year, it has dropped by -$12.54 million (-59.08%). CARA TTM revenue is now -93.57% below its all-time high of $135.08 million, reached on 31 December 2020.CARA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -49.9% | -47.5% | -59.1% |
| 3 y3 years | -84.5% | -87.4% | -93.5% |
| 5 y5 years | +55.7% | -55.8% | -58.5% |
CARA Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -84.5% | at low | -88.9% | +211.3% | -93.5% | at low |
| 5 y | 5 years | -84.5% | +55.7% | -97.7% | +211.3% | -93.6% | at low |
| alltime | all time | -84.5% | >+9999.0% | -97.7% | >+9999.0% | -93.6% | +777.4% |
Cara Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.56 M(+157.9%) | $8.69 M(-21.0%) |
| June 2024 | - | $991.00 K(-53.6%) | $11.00 M(-35.1%) |
| Mar 2024 | - | $2.13 M(-28.9%) | $16.94 M(-19.2%) |
| Dec 2023 | $20.97 M(-49.9%) | $3.00 M(-38.3%) | $20.97 M(-1.2%) |
| Sept 2023 | - | $4.87 M(-29.8%) | $21.23 M(-21.9%) |
| June 2023 | - | $6.93 M(+12.5%) | $27.17 M(-37.2%) |
| Mar 2023 | - | $6.17 M(+89.1%) | $43.24 M(+3.3%) |
| Dec 2022 | $41.87 M(+81.8%) | $3.26 M(-69.8%) | $41.87 M(+6.2%) |
| Sept 2022 | - | $10.81 M(-53.0%) | $39.43 M(-19.3%) |
| June 2022 | - | $23.00 M(+380.2%) | $48.89 M(+88.9%) |
| Mar 2022 | - | $4.79 M(+483.4%) | $25.88 M(+12.4%) |
| Dec 2021 | $23.03 M(-83.0%) | $821.00 K(-96.0%) | $23.03 M(-82.9%) |
| Sept 2021 | - | $20.27 M(+947.6%) | $134.30 M(+4.2%) |
| Mar 2021 | - | $1.94 M(-98.3%) | $128.92 M(-4.6%) |
| Dec 2020 | $135.08 M(+579.3%) | $112.09 M(+1109.7%) | $135.08 M(+391.1%) |
| Sept 2020 | - | $9.27 M(+64.5%) | $27.50 M(+14.5%) |
| June 2020 | - | $5.63 M(-30.4%) | $24.02 M(+1.8%) |
| Mar 2020 | - | $8.09 M(+79.4%) | $23.60 M(+18.7%) |
| Dec 2019 | $19.89 M | $4.51 M(-22.0%) | $19.89 M(-4.9%) |
| Sept 2019 | - | $5.79 M(+11.1%) | $20.91 M(+3.6%) |
| June 2019 | - | $5.21 M(+18.8%) | $20.18 M(+13.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $4.38 M(-20.8%) | $17.85 M(+32.5%) |
| Dec 2018 | $13.47 M(+1378.5%) | $5.53 M(+9.3%) | $13.47 M(+69.7%) |
| Sept 2018 | - | $5.06 M(+76.1%) | $7.94 M(+176.1%) |
| June 2018 | - | $2.87 M(+215.5%) | $2.87 M(+190.3%) |
| Dec 2017 | $911.00 K(+959.3%) | - | - |
| Mar 2017 | - | $911.00 K(+1053.2%) | $990.00 K(-60.8%) |
| Dec 2016 | $86.00 K(-97.7%) | - | - |
| June 2016 | - | $79.00 K(+1028.6%) | $2.53 M(-23.9%) |
| Mar 2016 | - | $7000.00(-99.7%) | $3.32 M(-29.6%) |
| Dec 2015 | $3.80 M(+19.7%) | - | - |
| Sept 2015 | - | $2.44 M(+179.2%) | $4.72 M(+38.7%) |
| June 2015 | - | $874.00 K(+78.7%) | $3.40 M(-2.5%) |
| Mar 2015 | - | $489.00 K(-46.5%) | $3.49 M(+9.8%) |
| Dec 2014 | $3.18 M(-73.4%) | $914.00 K(-18.8%) | $3.18 M(-1.8%) |
| Sept 2014 | - | $1.13 M(+17.2%) | $3.24 M(+3.4%) |
| June 2014 | - | $960.00 K(+439.3%) | $3.13 M(-74.2%) |
| Mar 2014 | - | $178.00 K(-81.7%) | $12.14 M(+1.5%) |
| Dec 2013 | $11.96 M(+905.4%) | $973.00 K(-4.4%) | $11.96 M(+8.9%) |
| Sept 2013 | - | $1.02 M(-89.8%) | $10.99 M(+10.2%) |
| June 2013 | - | $9.97 M | $9.97 M |
| Dec 2012 | $1.19 M | - | - |
FAQ
- What is Cara Therapeutics annual revenue?
- What is the all time high annual revenue for Cara Therapeutics?
- What is Cara Therapeutics annual revenue year-on-year change?
- What is Cara Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Cara Therapeutics?
- What is Cara Therapeutics quarterly revenue year-on-year change?
- What is Cara Therapeutics TTM revenue?
- What is the all time high TTM revenue for Cara Therapeutics?
- What is Cara Therapeutics TTM revenue year-on-year change?
What is Cara Therapeutics annual revenue?
The current annual revenue of CARA is $20.97 M
What is the all time high annual revenue for Cara Therapeutics?
Cara Therapeutics all-time high annual revenue is $135.08 M
What is Cara Therapeutics annual revenue year-on-year change?
Over the past year, CARA annual revenue has changed by -$20.90 M (-49.92%)
What is Cara Therapeutics quarterly revenue?
The current quarterly revenue of CARA is $2.56 M
What is the all time high quarterly revenue for Cara Therapeutics?
Cara Therapeutics all-time high quarterly revenue is $112.09 M
What is Cara Therapeutics quarterly revenue year-on-year change?
Over the past year, CARA quarterly revenue has changed by -$2.31 M (-47.47%)
What is Cara Therapeutics TTM revenue?
The current TTM revenue of CARA is $8.69 M
What is the all time high TTM revenue for Cara Therapeutics?
Cara Therapeutics all-time high TTM revenue is $135.08 M
What is Cara Therapeutics TTM revenue year-on-year change?
Over the past year, CARA TTM revenue has changed by -$12.54 M (-59.08%)